ISOPP Immunotherapy Survey

Immunotherapy is an important emerging therapy in the treatment of malignant disease. ISOPP recognises and supports the contributions of pharmacy staff across international healthcare systems in providing safe and effective care to patients receiving treatment with immunotherapy agents.

ISOPP has established the Immunotherapy Task Force who are working to develop a White Paper on the role of oncology pharmacy staff in immunotherapy to identify current and ongoing educational and developmental needs of pharmacy professionals.

To this end, the ISOPP Immunotherapy Task Force has commissioned a survey to establish current practices across the globe and help identify and respond to the needs of the profession. This survey is anonymous, and responses will be collated and summarized into a final publication which will detail the steps ISOPP will take to support the pharmacy staff.

Please complete this survey by Thursday, May 6, 2021 via the link below. It will take 10-15 minutes and results will help us to identify areas where the profession feels additional support is required and allow us to champion the role of pharmacy staff in the field of immunotherapy.

Access the Survey HERE: https://www.surveymonkey.com/r/WQ6GGR5

Latest News

By NHS Infusions and Special Medicines Programme on 4th September 2026

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications The Infusions and Special Medicines Programme is inviting expressions of interest for…

Read article
By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article
By BOPA Executive Committee on 31st August 2026

BOPA 2026 Executive Committee Election – One week left to cast your vote

One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future.   In 2026 we received 9 nominations for 6 positions. -Standard…

Read article
By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article